{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:20:00Z","timestamp":1790695200803,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The roles of implantable cardioverter-defibrillators (ICDs) and radiofrequency catheter ablation (RCA) in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and well-tolerated monomorphic ventricular tachycardia (MVT) are debated. In this multicentre retrospective study, we aimed at reporting the outcome of selected patients with ARVC after RCA without a back-up ICD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Patients with ARVC who underwent RCA of well-tolerated MVT at 10 tertiary centres across 5 countries, without an ICD before and 3\u2009months after RCA, without syncope or electrical storm, and with left ventricular ejection fraction \u226550% were included. In total, 65 ARVC patients [mean age 44.5\u2009\u00b1\u200913.2\u2009years, 78% males] underwent RCA of MVT between 2003 and 2016. Clinical presentation was palpitations in 51 (80%) patients. One (2%) patient had &amp;gt;1 clinical MVT. At the ablative procedure, clinical MVTs (mean rate 185\u2009\u00b1\u200932 b.p.m.) were inducible in 50 (81%) patients. Epicardial ablation was performed in 19 (29%) patients. Complete acute success was achieved in 47 (72%) patients. After a median follow-up of 52.4\u2009months (range 12.3\u2013171.4), there was no death or aborted cardiac arrest, and VT recurred in 19 (29%) patients. Survival without VT recurrence was estimated at 88%, 80%, and 68%, 12, 36, and 60 months after RCA, respectively, and was significantly associated with the approach and the procedural outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion\u2003<\/jats:title>\n                  <jats:p>In patients with ARVC, well-tolerated MVT without a back-up ICD did not lead to fatal arrhythmic event after RCA despite VT recurrences in some. Our data suggest that RCA may be an alternative to ICD in selected ARVC patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euab172","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T19:13:22Z","timestamp":1624389202000},"page":"1428-1436","source":"Crossref","is-referenced-by-count":14,"title":["Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy"],"prefix":"10.1093","volume":"23","author":[{"given":"Estelle","family":"Gandjbakhch","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, AP-HP, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, Institut de Cardiologie, 47-83 boulevard de l\u2019H\u00f4pital, 75013 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7326-2656","authenticated-orcid":false,"given":"Mikael","family":"Laredo","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, AP-HP, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, Institut de Cardiologie, 47-83 boulevard de l\u2019H\u00f4pital, 75013 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0543-2131","authenticated-orcid":false,"given":"Antonio","family":"Berruezo","sequence":"additional","affiliation":[{"name":"Departement of Cardiology, Centro M\u00e9dico Teknon, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Basptiste","family":"Gourraud","sequence":"additional","affiliation":[{"name":"L'Institut du Thorax, D\u00e9partement de Cardiologie et Centre de R\u00e9f\u00e9rence des Maladies Cardiaques H\u00e9r\u00e9ditaires, INSERM U1087, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Sellal","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Cardiologie, Centre Hospitalier Universitaire (CHU de Nancy), Vand\u0153uvre l\u00e8s-Nancy, France, INSERM-IADI U1254, Vand\u0153uvre l\u00e8s-Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Martins","sequence":"additional","affiliation":[{"name":"Service de Cardiologie et Maladies Vasculaires, CHU Rennes, Rennes, France; Universit\u00e9 de Rennes 1, Rennes, France; U1099, INSERM, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Sacher","sequence":"additional","affiliation":[{"name":"LIRYC Institute (L'Institut de RYthmologie et de modelisation Cardiaque); D\u00e9partment de Cardiologie, H\u00f4pital Universitaire de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Pison","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost Limburg, Genk, Belgium"},{"name":"Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1386-9285","authenticated-orcid":false,"given":"Etienne","family":"Pruvot","sequence":"additional","affiliation":[{"name":"D\u00e9partment de Cardiologie, Lausanne University Hospital, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"J\u00e1uregui","sequence":"additional","affiliation":[{"name":"Departement of Cardiology, Centro M\u00e9dico Teknon, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Frontera","sequence":"additional","affiliation":[{"name":"Arrhythmia Department, San Raffaele Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Westmead Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6484-4961","authenticated-orcid":false,"given":"Tom","family":"Wong","sequence":"additional","affiliation":[{"name":"Heart Rhythm Center, Royal Brompton and Harefield NHS Foundation Trust, Imperial College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"DellaBella","sequence":"additional","affiliation":[{"name":"Heart Rhythm Center, Royal Brompton and Harefield NHS Foundation Trust, Imperial College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4800-1841","authenticated-orcid":false,"given":"Philippe","family":"Maury","sequence":"additional","affiliation":[{"name":"Cardiology Division, Toulouse Rangueil University Hospital, INSERM U1048, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"key":"2021090908323210700_euab172-B1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jacc.2018.05.065","article-title":"Clinical diagnosis, imaging, and genetics of arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"72","author":"Gandjbakhch","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2021090908323210700_euab172-B2","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCEP.115.003562","article-title":"Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Santangeli","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2021090908323210700_euab172-B3","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/CIRCEP.113.000392","article-title":"Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications","volume":"6","author":"Schinkel","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2021090908323210700_euab172-B4","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1016\/j.hrthm.2019.09.019","article-title":"HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"2021090908323210700_euab172-B5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jacep.2018.09.019","article-title":"Outcomes of catheter ablation in arrhythmogenic right ventricular cardiomyopathy without background implantable cardioverter defibrillator therapy","volume":"5","author":"Santangeli","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"2021090908323210700_euab172-B6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.hrthm.2014.12.018","article-title":"Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"12","author":"Philips","year":"2015","journal-title":"Heart Rhythm"},{"key":"2021090908323210700_euab172-B7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.hrthm.2019.06.022","article-title":"Catheter ablation of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"17","author":"Laredo","year":"2020","journal-title":"Heart Rhythm"},{"key":"2021090908323210700_euab172-B8","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/01.CIR.0000103130.33451.D2","article-title":"Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"108","author":"Corrado","year":"2003","journal-title":"Circulation"},{"key":"2021090908323210700_euab172-B9","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia proposed modification of the task force criteria","volume":"31","author":"Marcus","year":"2010","journal-title":"Eur Heart J"},{"key":"2021090908323210700_euab172-B10","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/CIRCULATIONAHA.111.043216","article-title":"Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia","volume":"125","author":"Jais","year":"2012","journal-title":"Circulation"},{"key":"2021090908323210700_euab172-B11","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/europace\/euw062","article-title":"Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation","volume":"19","author":"Kirubakaran","year":"2017","journal-title":"Europace"},{"key":"2021090908323210700_euab172-B12","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/eurheartj\/ehu040","article-title":"Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%","volume":"35","author":"Maury","year":"2014","journal-title":"Eur Heart J"},{"key":"2021090908323210700_euab172-B13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jacep.2018.04.017","article-title":"Risk stratification in arrhythmogenic right ventricular cardiomyopathy\/dysplasia without an implantable cardioverter-defibrillator","volume":"4","author":"Maupain","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2021090908323210700_euab172-B14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"2021090908323210700_euab172-B15","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","article-title":"A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"40","author":"Cadrin-Tourigny","year":"2019","journal-title":"Eur Heart J"},{"key":"2021090908323210700_euab172-B16","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jacc.2011.06.043","article-title":"Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention","volume":"58","author":"Bhonsale","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2021090908323210700_euab172-B17","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIRCULATIONAHA.109.913871","article-title":"Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia","volume":"122","author":"Corrado","year":"2010","journal-title":"Circulation"},{"key":"2021090908323210700_euab172-B18","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.amjcard.2005.11.048","article-title":"Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?","volume":"97","author":"Germano","year":"2006","journal-title":"Am J Cardiol"},{"key":"2021090908323210700_euab172-B19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2014.04.035","article-title":"Ventricular arrhythmias in the North American multidisciplinary study of ARVC","volume":"64","author":"Link","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2021090908323210700_euab172-B20","doi-asserted-by":"crossref","first-page":"euw212","DOI":"10.1093\/europace\/euw212","article-title":"Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study","author":"Berruezo","year":"2016","journal-title":"Europace"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/23\/9\/1428\/40330320\/euab172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/23\/9\/1428\/40330320\/euab172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T08:33:49Z","timestamp":1631176429000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/23\/9\/1428\/6356827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,8,24]]},"published-print":{"date-parts":[[2021,9,8]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euab172","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,8,24]]}}}